Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription Articles published in Histopathology Retrieve available abstracts of 28 articles: HTML format

Single Articles

May 2024
1. ANGELICO G, Salvatorelli L, Tinnirello G, Santoro A, et al
   The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis.
   Histopathology. 2024;84:1068-1070.
   PubMed    
   
   
   March 2024
2. KOMMOSS FKF
   Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
   Histopathology. 2024;84:712-714.
   PubMed     Abstract available
   
   
   
3. KOMMOSS FKF, Chong AS, Apellaniz-Ruiz M, Turashvili G, et al
   Teratoma-associated and so-called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features.
   Histopathology. 2024;84:683-696.
   PubMed     Abstract available
   
   
   January 2024
4. MCCLUGGAGE WG
   Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
   Histopathology. 2024;84:288-290.
   PubMed    
   
   
   
5. NEIL AJ, Li YY, Hakam A, Nucci MR, et al
   Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
   Histopathology. 2024;84:369-380.
   PubMed     Abstract available
   
   
   
6. NEYRAND S, Trecourt A, Lopez J, Just PA, et al
   Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
   Histopathology. 2024;84:291-300.
   PubMed     Abstract available
   
   
   September 2023
7. MACHUCA-AGUADO J, McCluggage WG
   'STIC-like' lesions in ovarian low-grade serous carcinoma: a diagnostic pitfall.
   Histopathology. 2023;83:489-492.
   PubMed    
   
   
   
8. RICCI C, Ambrosi F, Franceschini T, Giunchi F, et al
   FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
   Histopathology. 2023;83:465-476.
   PubMed     Abstract available
   
   
   July 2023
9. THORNE H, Devereux L, Li J, Alsop K, et al
   BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
   Histopathology. 2023;83:91-103.
   PubMed     Abstract available
   
   
   
10. BOGAERTS JMA, van Bommel MHD, Hermens RPMG, Steenbeek MP, et al
    Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study.
    Histopathology. 2023;83:67-79.
    PubMed     Abstract available
    
    
    June 2023
11. MIRKOVIC J, Olkhov-Mitsel E, Amemiya Y, Al-Hussaini M, et al
    Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas.
    Histopathology. 2023;82:978-990.
    PubMed     Abstract available
    
    
    November 2022
12. VANG R, Shih IM
    Serous tubal intra-epithelial carcinoma: what do we really know at this point?
    Histopathology. 2022;81:542-555.
    PubMed     Abstract available
    
    
    September 2022
13. BENNETT JA, Oliva E
    The complex and often confusing history, histology and histogenesis of mesonephric, STK11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament).
    Histopathology. 2022;81:280-296.
    PubMed     Abstract available
    
    
    July 2022
14. KIHARA A, Amano Y, Fukushima N, Fujiwara H, et al
    ZEB1 expression is frequently detected in undifferentiated and de-differentiated carcinomas, but is not specific among endometrial carcinomas.
    Histopathology. 2022;81:108-118.
    PubMed     Abstract available
    
    
    
15. TESSIER-CLOUTIER B, Kang EY, Alex D, Stewart CJR, et al
    Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression.
    Histopathology. 2022;81:44-54.
    PubMed     Abstract available
    
    
    June 2022
16. AOUN BA, Skala SL
    Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
    Histopathology. 2022;80:1102-1111.
    PubMed     Abstract available
    
    
    May 2022
17. PARRA-HERRAN C, McCluggage WG
    Ovarian microcystic stromal tumour: from morphological observations to syndromic associations.
    Histopathology. 2022;80:898-904.
    PubMed     Abstract available
    
    
    January 2022
18. DEVINS KM, Young RH, Watkins JC
    Sclerosing stromal tumour: a clinicopathological study of 100 cases of a distinctive benign ovarian stromal tumour typically occurring in the young.
    Histopathology. 2022;80:360-368.
    PubMed     Abstract available
    
    
    
19. RAJENDRAN S, McCluggage WG
    Tubo-ovarian high-grade serous carcinomas commonly express CA19.9.
    Histopathology. 2022;80:449-450.
    PubMed    
    
    
    
20. MUNDADA A, Kakkar A, Menon S
    Paratesticular endometrioid adenocarcinoma of the ovarian surface epithelial type with neuroendocrine differentiation: an undescribed entity.
    Histopathology. 2022;80:443-445.
    PubMed    
    
    
    
21. TALIA KL, Parra-Herran C, McCluggage WG
    Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach.
    Histopathology. 2022;80:255-278.
    PubMed     Abstract available
    
    
    December 2021
22. LIN LH, Zamuco RD, Shukla PS
    Intratumoral budding is associated with poor clinical outcome in early-stage clear cell carcinoma of ovary.
    Histopathology. 2021;79:1018-1029.
    PubMed     Abstract available
    
    
    November 2021
23. LIN SY, Wang YH, Hsu CY, Chen YJ, et al
    Analytical validation of human epidermal growth factor receptor 2 immunohistochemistry by the use of the A0485 antibody versus the 4B5 antibody and breast versus gastric scoring guidelines in ovarian clear cell carcinoma.
    Histopathology. 2021;79:758-767.
    PubMed     Abstract available
    
    
    
24. HACHISUGA K, Ohishi Y, Tomonobe H, Yahata H, et al
    Endometrial endometrioid carcinoma, grade 1, is more aggressive in the elderly than in the young.
    Histopathology. 2021;79:708-719.
    PubMed     Abstract available
    
    
    July 2021
25. WORRELL HI, Sciallis AP, Skala SL
    Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
    Histopathology. 2021;79:96-105.
    PubMed     Abstract available
    
    
    March 2021
26. KOMMOSS FKF, Cheasley D, Wakefield MJ, Scott CL, et al
    Primary mucinous ovarian neoplasms rarely show germ cell histogenesis.
    Histopathology. 2021;78:640-642.
    PubMed    
    
    
    February 2021
27. BEN-MUSSA A, McCluggage WG
    Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series.
    Histopathology. 2021;78:445-452.
    PubMed     Abstract available
    
    
    July 2020
28. BUSCA A, Nofech-Mozes S, Olkhov-Mitsel E, Gien LT, et al
    Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of traditional and novel systems.
    Histopathology. 2020;77:26-34.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.